Advance Therapy Medicinal Products (ATMP) definitions
Advance Therapy Medicinal Products (ATMPs) are medicinal products which are prepared industrially or manufactured by a method involving an industrial process. ATMPs fall into three categories; Gene Therapies, Somatic Cell Therapies and Tissue Engineered Products.
The Regulatory Advice Service for Regenerative Medicine (RASRM)
RASRM is a ‘one stop shop’ for research and development professionals across academia, industry, and the NHS. It offers a single point of access to free, clear, expert responses to queries about the regulation of regenerative medicines.
The HTA launch new beta website!
The Human Tissue Authority (HTA) has today launched the beta (draft) version of our new website and we want your feedback!
The new website is part of our ongoing commitment to enhance the quality and accessibility of the information we provide to professionals working in areas we regulate, and members of the public who our regulation protects.
There are two ways you can give your feedback about the new site:
Guidance for establishments in the event of supply disruption resulting from the UK exiting the EU
The following guidance has been issued to set out the HTA’s expectations regarding the use of alternative reagents and materials during the processing of tissues and cells in the event there is a supply disruption to critical reagents and materials as a result of the UK exiting the EU.